✦ LIBER ✦

Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs

✍ Scribed by T. L. BIDGOOD; M. G. PAPICH

Book ID: 108884935
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 217 KB
Volume: 28
Category: Article
ISSN: 0140-7783
DOI: 10.1111/j.1365-2885.2005.00664.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of Enrofloxacin and Its

Pharmacokinetics of Enrofloxacin and Its Metabolite Ciprofloxacin in Male and Female Turkeys following Intravenous and Oral Administration

✍ D. J. Dimitrova; L. D. Lashev; St. G. Yanev; V. T. Pandova 📂 Article 📅 2006 🏛 Springer Netherlands 🌐 English ⚖ 139 KB

Pharmacokinetics of vinpocetine and its

Pharmacokinetics of vinpocetine and its metabolite, apovincaminic acid, in plasma and cerebrospinal fluid after intravenous infusion

✍ Margarita Polgár; László Vereczkey; István Nyáry 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 641 KB

The pharmacokinetics of vinpocetine (ethyl apovincaminate, Cavinton) and its metabolite, apovincaminic acid, was studied in patients with cerebrovascular disorders. Vinpocetine (1 mg/kg) was infused intravenously over 25 min. The elimination half-life of the parent drug in plasma was 4.7k2.13 h. Tot

Pharmacokinetics of ketanserin and its m

Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration

✍ J. Heykants; A. Van Peer; R. Woestenborghs; S. Gould; J. Mills 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 817 KB

Pharmacokinetics of monepantel and its s

Pharmacokinetics of monepantel and its sulfone metabolite, monepantel sulfone, after intravenous and oral administration in sheep

✍ D. KARADZOVSKA; W. SEEWALD; A. BROWNING; M. SMAL; J. BOUVIER; J. M. GIRAUDEL 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

The plasma and cerebrospinal fluid pharm

The plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite (OSI-420) after intravenous administration of erlotinib in non-human primates

✍ Holly J. Meany; Elizabeth Fox; Cynthia McCully; Chris Tucker; Frank M. Balis 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 274 KB